Staubach, P
Diagnostik und Therapie verschiedener UrtikariaformenMedReport. Bd. 30. H. 26. 2006 S. 12
Lopez-Kostka, S; Knop, J; Konur, A et al.
Distinct roles for IL-1 receptor type I signaling in early versus established Leishmania major infections.J Invest Dermatol. Bd. 126. H. 7. 2006 S. 1582-9
Steitz, J; Britten, CM; Wolfel, T et al.
Effective induction of anti-melanoma immunity following genetic vaccination with synthetic mRNA coding for the fusion protein EGFP.TRP2.Cancer Immunol Immunother. Bd. 55. H. 3. 2006 S. 246-53
Steitz, J; Buchs, S; Tormo, D et al.
Evaluation of genetic melanoma vaccines in cdk4-mutant mice provides evidence for immunological tolerance against authochthonous melanomas in the skin.Int J Cancer. Bd. 118. H. 2. 2006 S. 373-80
Bork, K; Gül, D; Dewald, G
Hereditary angio-oedema with normal C1 inhibitor in a family with affected women and men.Br J Dermatol. Bd. 154. H. 3. 2006 S. 542-545
Bork, K
Hereditary angioedema with normal C1 inhibitor activity including hereditary angioedema with coagulation factor XII gene mutations.Immunol Allergy Clin North Am. Bd. 26. H. 4. 2006 S. 709-24
Longhurst, HJ; Bork, K
Hereditary angioedema: causes, manifestations and treatment.Hosp Med. Bd. 67. H. 12. 2006 S. 654-657
Bork, K; Meng, G; Staubach, P et al.
Hereditary angioedema: new findings concerning symptoms, affected organs, and course.Am J Med. Bd. 119. H. 3. 2006 S. 267-74
Jansen, T; Grabbe, S
Im Schnitt zehn Jahre bis zur richtigen Diagnose. Kennen Sie die Zeichen des Morbus Fabry?MMW Fortschr Med. Bd. 148. H. 48. 2006 S. 46-7
Cichon, S; Martin, L; Hennies, HC et al.
Increased activity if coagulation factor XII (Hageman factor) causes hereditary angioedema type III.Am J Hum Genet. Bd. 79. H. 6. 2006 S. 1098-1104